Cytokinetics Statistics

Total Valuation

Cytokinetics has a market cap or net worth of EUR 6.65 billion. The enterprise value is 7.13 billion.

Market Cap	6.65B
Enterprise Value	7.13B

Important Dates

The last earnings date was Tuesday, February 24, 2026.

Earnings Date	Feb 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	123.16M
Shares Outstanding	n/a
Shares Change (YoY)	+7.26%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	112.99%
Float	122.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	88.66
PB Ratio	-11.83
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.67
EV / Sales	93.32
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-15.65

Financial Position

The company has a current ratio of 4.53

Current Ratio	4.53
Quick Ratio	4.45
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-2.69
Interest Coverage	-5.89

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-27.08%
Return on Invested Capital (ROIC)	-48.85%
Return on Capital Employed (ROCE)	-50.10%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	111,416
Profits Per Employee	-993,382
Employee Count	673
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	54.12
200-Day Moving Average	45.31
Relative Strength Index (RSI)	44.46
Average Volume (20 Days)	20

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.79

Income Statement

In the last 12 months, Cytokinetics had revenue of EUR 74.98 million and -668.55 million in losses. Loss per share was -5.57.

Revenue	74.98M
Gross Profit	-279.35M
Operating Income	-521.46M
Pretax Income	-668.55M
Net Income	-668.55M
EBITDA	-512.84M
EBIT	-521.46M
Loss Per Share	-5.57

Full Income Statement

Balance Sheet

The company has 751.39 million in cash and 1.23 billion in debt, with a net cash position of -474.07 million.

Cash & Cash Equivalents	751.39M
Total Debt	1.23B
Net Cash	-474.07M
Net Cash Per Share	n/a
Equity (Book Value)	-561.80M
Book Value Per Share	-4.57
Working Capital	608.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -434.37 million and capital expenditures -21.13 million, giving a free cash flow of -455.50 million.

Operating Cash Flow	-434.37M
Capital Expenditures	-21.13M
Free Cash Flow	-455.50M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-695.44%
Pretax Margin	-891.60%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cytokinetics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.26%
Shareholder Yield	-7.26%
Earnings Yield	-10.06%
FCF Yield	-6.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cytokinetics has an Altman Z-Score of -2.59 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.59
Piotroski F-Score	3